Champions Oncology Inc (FRA:2I3)
€ 3.9 0.06 (1.56%) Market Cap: 56.35 Mil Enterprise Value: 60.26 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 72/100

Q1 2024 Champions Oncology Inc Earnings Call Transcript

Sep 13, 2023 / 08:30PM GMT
Release Date Price: €6.05
Operator

Greetings. Welcome to the Champions Oncology first quarter fiscal year 2024 earnings call. (Operator Instructions) I will now turn the conference over to your host Dr. Ronnie Morris, CEO at Champions Oncology. You may begin.

Ronnie Morris
Champions Oncology, Inc. - President, and CEO

Good afternoon, I am Ronnie Morris, CEO, Champions Oncology. Joining me today is David Miller, Chief Financial Officer. Thank you for joining us for quarterly earnings call. Before I begin, I will remind you that we make forward looking statements during today's call, and that actual results could differ materially from what described in those statements.

Additional information on factors that could cause results to differ is available on our Form 10-Q, and Form 10-K. A reconciliation of non-GAAP financial measures that may be discussed during the call to GAAP financial measures is available in the earnings release.

I'll start by pointing out, that our prepared comments for today will be relatively brief, as we recently provided our fiscal year end results and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot